News

NEI News

 If a study participant were instructed to pay attention to “scenes” and he was attending well, he would be shown the top image as a reward. As his attention lapsed, the middle and bottom images would be shown. The face in the photograph is that of the study’s first author, Megan deBettencourt, a doctoral candidate at the Princeton Neuroscience Institute.

People are bad at staying focused. We’ve all had our minds wander when we try to concentrate on a task that requires paying close attention but isn’t all that engaging. But a new NIH-funded study suggests that one’s capacity to stay focused can improve with real-time feedback.

Posted on Feb 18, 2015
Illustration showing the retina as seen through a dilated pupil.

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial.

Posted on Feb 18, 2015
Degenerated RPE cells from mice with geographic atrophy are shown at left. Treating the mice with NRTIs protected the RPE cells. Photos courtesy of Jayakrishna Ambati, M.D.

A class of medications long used to curb HIV infection shows promise as a therapy for age-related macular degeneration (AMD), suggest findings from an NIH-funded study.

Posted on Dec 22, 2014

Budget and Congress

The NEI budget is approximately $675 million (FY2014). The NEI budget requests are submitted to Congress with other NIH institutes as part of the President’s budget request in February. See our Congressional Justifications.